Search results for: 'partner of frost sullivan'
- Related search terms
- frost amp sullivan's accountsignout helpcontactsitemap healthcare home research events blog forum peerconnect tags switch community
- frost amp sullivan believes that global nsps are investing between 50 billion and (6(6 billion) annually on their mobile and wireles
- Frost & Sullivan: Global and Chinese Pharmaceutical Market Research Report
- Sullivan Product Leadership Award - The Global EV Battery Testing Industry
- frost sullivan global ad chinese pharmaceutical market research report
-
12 Aug 2024  |  Global  |  Frost Radar
Frost Radar™: Laboratory Information Management Systems, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar for the laboratory information management systems (LIMS) industry benchmarks providers offering workflow management and paperless tracking capabilities to help improve process efficiencies for life sciences companies. LIMS have several functionalities, such as obtaining, storing, managing, retrieving, and recording laboratory data...
$4,950.00
Special Price $4,207.50 save 15 %
-
03 Nov 2020  |  North America  |  Frost Radar
Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020
A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines
Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Digital Pathology, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...
$4,950.00
Special Price $4,207.50 save 15 %
-
13 Aug 2024  |  Global  |  Frost Radar
Frost Radar™: Healthcare Data Interoperability, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies and their solutions that enable the exchange and use of data between healthcare applications. Interoperability improves continuity of care, increases communication and connectivity between different stakeholders (e.g., payors, providers, patients, public health bodies), and reduces inefficiencies. Organizat...
$4,950.00
Special Price $4,207.50 save 15 %
-
11 Nov 2024  |  Global  |  Frost Radar
Frost Radar™: US Population Health Management, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Operational, clinical, and financial challenges that result in inefficient resource utilization and suboptimal healthcare outcomes waste money and time and ultimately affect payers and providers’ ability to focus on preventive care and population health improvement. Frost & Sullivan defines population health management (PHM) as solutions and serv...
$4,950.00
Special Price $4,207.50 save 15 %
-
04 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Healthcare Data Analytics, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The healthcare industry is undergoing a data revolution, and analytics is at the heart of it. This Frost Radar will reveal the strategies, technologies, and innovations that are shaping the industry and driving success. By understanding the current landscape, digital health readers can stay ahead of the curve, identify emerging trends, and make in...
$4,950.00
Special Price $4,207.50 save 15 %
-
09 Nov 2022  |  Global  |  Technology Research
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Strategic partnering and new product development will enable better biologics for personalized and targeted treatment
Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00
Special Price $3,712.50 save 25 %